GSK (LON:GSK) Stock Rating Reaffirmed by Barclays

Barclays reissued their equal weight rating on shares of GSK (LON:GSK) in a report issued on Tuesday morning, Marketbeat.com reports. They currently have a GBX 1,725 ($21.67) target price on the stock.

GSK has been the topic of a number of other research reports. Deutsche Bank Aktiengesellschaft reissued a buy rating and issued a GBX 1,950 ($24.50) target price on shares of GSK in a research report on Wednesday, April 17th. Shore Capital reissued a buy rating on shares of GSK in a research report on Wednesday, May 1st. JPMorgan Chase & Co. boosted their target price on GSK from GBX 1,530 ($19.22) to GBX 1,660 ($20.85) and gave the company an underweight rating in a research report on Thursday, May 2nd. Finally, Berenberg Bank boosted their target price on GSK from GBX 1,650 ($20.73) to GBX 1,820 ($22.86) and gave the company a buy rating in a research report on Wednesday, February 14th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of Hold and a consensus price target of GBX 1,675.63 ($21.05).

GSK Stock Up 0.6 %

GSK stock opened at GBX 1,771 ($22.25) on Tuesday. The firm has a market cap of £72.43 billion, a PE ratio of 1,468.79, a PEG ratio of 1.12 and a beta of 0.27. The company has a debt-to-equity ratio of 140.82, a quick ratio of 0.73 and a current ratio of 0.88. The firm’s 50 day moving average price is GBX 1,666.29 and its 200-day moving average price is GBX 1,562.88. GSK has a one year low of GBX 1,302.60 ($16.36) and a one year high of GBX 1,772.50 ($22.27).

GSK Cuts Dividend

The business also recently disclosed a dividend, which will be paid on Thursday, July 11th. Stockholders of record on Thursday, May 16th will be given a dividend of GBX 15 ($0.19) per share. This represents a dividend yield of 0.9%. The ex-dividend date is Thursday, May 16th. GSK’s dividend payout ratio is currently 5,333.33%.

Insider Transactions at GSK

In other news, insider Emma Walmsley sold 139,792 shares of the company’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of GBX 1,658 ($20.83), for a total transaction of £2,317,751.36 ($2,911,747.94). In related news, insider Emma Walmsley sold 139,792 shares of the business’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of GBX 1,658 ($20.83), for a total transaction of £2,317,751.36 ($2,911,747.94). Also, insider Urs Rohner bought 434 shares of the stock in a transaction that occurred on Wednesday, March 20th. The shares were purchased at an average price of GBX 1,662 ($20.88) per share, with a total value of £7,213.08 ($9,061.66). Corporate insiders own 1.77% of the company’s stock.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.